Trade RXST anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
RxSight, Inc. (RXST) is trading at US$7.05, up 6.66% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$259.96M. Over the past 52 weeks, RXST has traded between US$4.48 and US$13.22. On Syfe you can trade RXST with $0 commission and add it to your watchlist.
| Previous close | US$6.61 |
|---|---|
| Market cap | US$259.96M |
| 52-week range | US$4.48 – US$13.22 |
| Volume | 662.36K |
| Exchange | US |
Add to Watchlist
Set Price Alert
RxSight, Inc.
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Year: 2021
UBS Adjusts Price Target on RxSight to $5.50 From $9, Maintains Neutral Rating
Jul 28, 2:34 PM · MT Newswires
RxSight Names Aziz Mottiwala as CEO
Jul 15, 8:43 PM · MT Newswires
Alcon, RxSight Launch Collaboration to Develop Adjustable Presbyopia-Correcting Lenses
Jul 6, 8:47 PM · MT Newswires
Needham Cuts Price Target on RxSight to $11 From $13, Keeps Buy Rating
May 7, 12:41 PM · MT Newswires
RxSight, Inc. (RXST) stock is trading at US$7.05, +6.66% from the previous close of US$6.61.
The market cap for RxSight, Inc. (RXST) stock is approximately US$259.96M.
The 52-week high for RxSight, Inc. (RXST) stock is US$13.22.
The 52-week low for RxSight, Inc. (RXST) stock is US$4.48.
RxSight, Inc. (RXST) does not currently pay a dividend.
Stay on top of RXST
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
